For Immediate Release September 16, 2018

Tate Cancer Center

GLEN BURNIE, MD – The Tate Cancer Center at University of Maryland Baltimore Washington Medical Center (UM BWMC) has received a three-year accreditation by the Commission on Cancer (CoC) and the American College of Surgeons as an Academic Comprehensive Cancer Program (ACAD). ACADs are cancer centers that provide post graduate medical education, treat and provide care to more than 500 newly diagnosed cancer patients each year, offer a full range of diagnostic and treatment services, and participate in cancer related clinical research. CoC accredited cancer programs are dedicated to providing the best in patient-centered care.

The Tate Cancer Center is one of only three ACAD programs in Maryland; and only 13 percent of all cancer programs in the United States have achieved this status. As a member of the University of Maryland Cancer Network, the Tate Cancer Center is affiliated with the University of Maryland Marlene and Stewart Greenebaum Cancer Center, which provides access to national experts, the latest treatments, leading edge technology and clinical trials.

“The Tate Cancer Center’s ACAD accreditation comes as we are celebrating our 15th anniversary,” said Cherif Boutros, M.D., MSc, Medical Director of the Tate Cancer Center; Chair, Surgical Oncology, University of Maryland Baltimore Washington Medical Center; and Associate Professor of Surgery, University of Maryland School of Medicine. “Our cancer program has also been recognized as a high performer in the areas of Lung Cancer Surgery and Colorectal Cancer Surgery by US News and World Report Best Hospitals for 2018-19.  As part of our academic mission we are sharing our experience with other hospitals in the state of Maryland and remain committed to our teaching and academic activity for the next generation of future cancer providers.”

According to the most recent statistics provided by the Anne Arundel County Health Department, cancer is the number one leading cause of death for county residents. Since opening in 2003, the Center has treated nearly 16,000 patients suffering from different types of the disease, including breast, lung, prostate and gastrointestinal cancers.
 
“We commend our staff at the Tate Cancer Center for receiving this accreditation, which is a direct reflection of their commitment to improve the quality of care for their patients,” said Karen E. Olscamp, President and CEO of UM BWMC. “Having the ACAD accreditation will continue to allow us to provide more treatments and offer nationally acclaimed clinical research trials to our patients.”

About the Tate Cancer Center UM Baltimore Washington Medical Center
The Tate Cancer Center has been approved by the Commission on Cancer (CoC) of the American College of Surgeons as an Academic Comprehensive Cancer Program (ACAD), which recognizes the highest quality care and commitment to treating cancer patients. Since its opening in 2003, the Tate Cancer Center has been affiliated with the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), and is part of the University of Maryland Cancer Network. The Network provides access to national experts, the latest treatments, leading edge technology and promising clinical trials — all close to home.


About the University of Maryland Marlene and Stewart Greenebaum Cancer Center
The University of Maryland Marlene and Stewart Greenebaum Cancer Center is a National Cancer Institute-designated Cancer Center, which is part of the University of Maryland Medical Center and the University of Maryland School of Medicine. The center is recognized for its active clinical and basic science research program. It has comprehensive programs to treat all types of cancer and is a major referral center for patients throughout Maryland and the region. It is ranked in the top 50 of 900 cancer centers nationwide by U.S. News and World Report.


###